fluorodeoxyuridine (FUDR)

also known as FUDR

Developed for: colorectal cancer
Investigated by: Ruijin Hospital · The Second Affiliated Hospital of Harbin Medical University · Xu jianmin · Zhejiang University

today NCT02402972 · Ph 3

2015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 3	NCT02402972	Feb 2015 → Feb 2020	colorectal cancer, metastatic neoplasm	Xu jianmin	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	fluorodeoxyuridine (FUDR)	“fluorodeoxyuridine (FUDR)” NCT02402972 ↗
Known as	FUDR	ClinicalTrials.gov intervention name — accepted as the source's own label NCT02402972 ↗
Route	Other	“administered as a bolus into the regional vein” NCT02402972 ↗